Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

This question can be hurtful, because it implies the person deserved to get the disease. The fact is, as many as 20 percent of people who die of lung cancer each year have never smoked or used any ...

Lung health experts think smoking anything at all, including weed, is not such a good idea. [2] “People should only inhale clean air,” says Janaki Deepak, MD, an expert on lung cancer and COPD ...

The first white ribbon campaign to raise awareness of lung cancer in Ireland has just launched thanks to the determined efforts of two patients described as "absolute powerhouses" in Cork and ...

Biomarker-specific therapies have improved outcomes but come at a high cost, contributing to lung cancer’s standing as one of the most expensive cancers to treat. In 2019 alone, out-of-pocket costs in ...

Background Lung cancer outcomes in the UK are worse than in many other developed nations. Symptom awareness campaigns aim to diagnose patients at an earlier stage to improve cancer outcomes. Methods ...

The Hormel Institute, University of Minnesota, along with Nu-Tek BioSciences have announced the inaugural Ribbon Research Open, a charity golf tournament taking place in Austin this August. Set ...

The Hormel Institute, University of Minnesota, and Nu-Tek BioSciences are proud to announce the inaugural Ribbon Research Open, a charity golf tournament taking place in Austin, Minnesota. Set for ...

The 5-year lung cancer-specific survival rate was 74.9% with nivolumab plus chemotherapy vs 65.1% with chemotherapy alone (HR, 0.65). No new safety concerns emerged, and there were no new deaths ...

A class of targeted therapies currently used to treat lung and other cancers may be effective for patients with a deadly form of drug-resistant melanoma, according to new research. The study, ...

RNAi-based technologies offer the potential to treat cancer effectively, but safe and efficient RNA administration remains a barrier to their clinical adoption. In this study, we developed ...

LOUISVILLE, Ky. (WAVE) - Reports say cancer kills more than 600,000 people per year in the United States. Many times, patients run out of options and are faced with the inevitable. Doctors at the ...